UniQure NV (QURE) - Financial and Strategic SWOT Analysis Review

  • ID: 4278442
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 5


  • Applikon Biotechnology BV
  • arGEN-X BV
  • Hycult Biotech BV
  • Mediclin AG
  • OcellO BV
  • ProQR Therapeutics NV
  • MORE

UniQure NV (UniQure), formerly uniQure BV is a pharmaceutical company that develops and markets gene therapy products. The company develops adeno-associated virus based gene therapies by using its modular technology platform. Its glybera is used to restore the LPL enzyme activity. UniQure offers clinical and preclinical programs for lipoprotein lipase deficiency, hemophilia B, sanfilippo B syndrome, acute intermittent porphyria, congestive heart failure and Parkinson’s disease. The company develops a modular platform to bring new disease modifying therapies to patients with genetic diseases. It provides clinical proof-of-concept in hemophilia B, and preclinical Huntington’s disease. UniQure also develops gene therapies for cardiovascular diseases. The company conducts drug discovery and preclinical research in collaboration with academic research institutions. It also develops its gene therapies using a modular technology platform. UniQure is headquartered in Amsterdam, the Netherlands.

UniQure NV Key Recent Developments

Feb 27, 2018: uniQure to Participate in Multiple Conferences in March
Jan 08, 2018: uniQure Provides Year-End 2017 Corporate Update and Outlines Near-Term Objectives to Further Drive Shareholder Value
Dec 11, 2017: uniQure Added to NASDAQ Biotechnology Index
Nov 01, 2017: uniQure Announces Third Quarter 2017 Financial Results and Recent Company Progress
Oct 31, 2017: uniQure Announces Multiple Company Presentations at Upcoming November Conferences

This comprehensive SWOT profile of UniQure NV provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of UniQure NV including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 5


  • Applikon Biotechnology BV
  • arGEN-X BV
  • Hycult Biotech BV
  • Mediclin AG
  • OcellO BV
  • ProQR Therapeutics NV
  • MORE
Section 1 - About the Company
  • UniQure NV - Key Information
  • UniQure NV - Overview
  • UniQure NV - Key Employees
  • UniQure NV - Key Employee Biographies
  • UniQure NV - Key Operational Heads
  • UniQure NV - Major Products and Services
  • UniQure NV - History
  • UniQure NV - Company Statement
  • UniQure NV - Locations And Subsidiaries
  • UniQure NV - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • UniQure NV - Business Description
  • UniQure NV - Corporate Strategy
  • UniQure NV - SWOT Analysis
  • SWOT Analysis - Overview
  • UniQure NV - Strengths
  • UniQure NV - Weaknesses
  • UniQure NV - Opportunities
  • UniQure NV - Threats
  • UniQure NV - Key Competitors
Section 3 - Company Financial Performance Charts
  • UniQure NV - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • UniQure NV, Key Information
  • UniQure NV, Key Ratios
  • UniQure NV, Share Data
  • UniQure NV, Major Products and Services
  • UniQure NV, History
  • UniQure NV, Key Employees
  • UniQure NV, Key Employee Biographies
  • UniQure NV, Key Operational Heads
  • UniQure NV, Other Locations
  • UniQure NV, Subsidiaries
  • UniQure NV, Key Manufacturing facilities
  • UniQure NV, Key Competitors
  • UniQure NV, SWOT Analysis
  • UniQure NV, Ratios based on current share price
  • UniQure NV, Annual Ratios
  • UniQure NV, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • UniQure NV, Performance Chart
  • UniQure NV, Ratio Charts
Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • ProQR Therapeutics NV
  • OcellO BV
  • Mediclin AG
  • Hycult Biotech BV
  • arGEN-X BV
  • Applikon Biotechnology BV
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown